B+
Bull case
20%
Probability
Target price
$1.20
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
IRIX
IRIDEXBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
IRIDEX is showing a potentially meaningful glaucoma-led inflection: Cyclo G6 demand is growing, operating cash flow turned positive, operating expenses declined, and restructuring could improve the cost base. Retina recovery would provide additional upside.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Failure to regain Nasdaq minimum-bid compliance by February 23, 2027 could create delisting and financing pressure [#8-K-2026-09-02].
Momentum
77
Value
37
Sentiment
78
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.78 · Bull $1.20 · Bear $0.35Analysis 2026-09-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $2.75
Why
Momentum77 · Δ7d -
Value37 · Δ7d -0.0
Sentiment78 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Failure to regain Nasdaq minimum-bid compliance by February 23, 2027 could create delisting and financing pressure [#8-K-2026-09-02].
- • Gross margin remains constrained during the transition to lower-cost contract manufacturing [#SEC-8K-2026-05-19].
- • Total revenue fell 7%, retina remains weak, gross margin was approximately flat year over year, and the Nasdaq minimum-bid deficiency creates a material binary risk.
Catalyst clock
2026-12-03
Retina recovery and regulatory progress
Lead driver: Sentiment · See AI snapshot
Momentum
77
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
78
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 77.3 / Value 36.6 / Sentiment 77.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$0.78
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.35
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$15.32M
Beta
0.70
Shares Out
17.41M
P/E (TTM) · Derived
-3.4
P/S (TTM)
0.41
P/FCF (TTM) · Derived
-7.55
Rev YoY
-7.4%
EPS YoY
+22.8%
Gross Margin
+35.3%
Op Margin
-5.4%
Net Debt
-$1.5M
Current Ratio
1.82
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data